Kristian Reich, Chief Scientific Officer at MoonLake Immunotherapeutics (MLTX), sold 118,922 shares at $55.00 ($6.5M) on 2024-02-28, disclosed to the SEC on 2024-02-29.
Scheduled sale ($6.5M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.00 | 29,431 | $1.6M | 24.7% |
| 2 | $55.00 | 29,491 | $1.6M | 24.8% |
| 3 | $55.00 | 28,090 | $1.5M | 23.6% |
| 4 | $55.00 | 31,910 | $1.8M | 26.8% |
| Total | $55.00 avg | 118,922 | $6.5M | 100% |
| Filing → |
| MLTX | SELL | 2026-07-21 | $878K | — | Filing → |
| MLTX | SELL | 2026-07-20 | $322K | — | Filing → |
| MLTX | SELL | 2026-06-17 | $2.9M | — | Filing → |